These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 16503864)
1. HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol. Kleemann R; Kooistra T Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):441-53. PubMed ID: 16503864 [TBL] [Abstract][Full Text] [Related]
2. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Zhou Q; Liao JK Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975 [TBL] [Abstract][Full Text] [Related]
3. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis. Arnaud C; Veillard NR; Mach F Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):127-34. PubMed ID: 15853754 [TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583 [TBL] [Abstract][Full Text] [Related]
5. Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms. Liberale L; Carbone F; Montecucco F; Sahebkar A Int J Biochem Cell Biol; 2020 May; 122():105735. PubMed ID: 32126319 [TBL] [Abstract][Full Text] [Related]
8. Potential role of statins in inflammation and atherosclerosis. Yoshida M J Atheroscler Thromb; 2003; 10(3):140-4. PubMed ID: 14564082 [TBL] [Abstract][Full Text] [Related]
11. [The pleiotropic effects of statins]. Wolfovitz E Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158 [TBL] [Abstract][Full Text] [Related]
12. Inflammation and the development of atherosclerosis. Mizuno Y; Jacob RF; Mason RP J Atheroscler Thromb; 2011; 18(5):351-8. PubMed ID: 21427505 [TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Lennernäs H; Fager G Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173 [TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of HMG-CoA reductase inhibitors. Werner N; Nickenig G; Laufs U Basic Res Cardiol; 2002 Mar; 97(2):105-16. PubMed ID: 12002257 [TBL] [Abstract][Full Text] [Related]
15. Altering the pathophysiology of atherosclerosis: the multidimensional role of statins. Clearfield MB J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 4):S2-6. PubMed ID: 20453192 [TBL] [Abstract][Full Text] [Related]
16. Statins and Inflammation. Satny M; Hubacek JA; Vrablik M Curr Atheroscler Rep; 2021 Dec; 23(12):80. PubMed ID: 34851454 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review. Kouhpeikar H; Delbari Z; Sathyapalan T; Simental-Mendía LE; Jamialahmadi T; Sahebkar A Curr Atheroscler Rep; 2020 May; 22(5):19. PubMed ID: 32458165 [TBL] [Abstract][Full Text] [Related]
18. Statin therapy-evidence beyond lipid lowering contributing to plaque stability. de Lorenzo F; Feher M; Martin J; Collot-Teixeira S; Dotsenko O; McGregor JL Curr Med Chem; 2006; 13(28):3385-93. PubMed ID: 17168712 [TBL] [Abstract][Full Text] [Related]
19. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia. Miida T; Hirayama S; Nakamura Y J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707 [TBL] [Abstract][Full Text] [Related]
20. Update on statin-mediated anti-inflammatory activities in atherosclerosis. Montecucco F; Mach F Semin Immunopathol; 2009 Jun; 31(1):127-42. PubMed ID: 19415282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]